About: Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti-CD52 antibodies

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti-CD52 antibodies Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 September 2004

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 2004 (uk) artículu científicu espublizáu en setiembre de 2004 (ast) scientific article published on 01 September 2004 (en)
publication date	wds:Q80493152-8F79DD7B-4F37-4316-A81B-D342E58982C8
publication date	2004-09-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q80493152-17CADDC4-75A0-4A4E-B0A3-569F84E8C3ED wds:Q80493152-29F754D5-C3E2-4845-8820-2B56AA6FE5E1 wds:Q80493152-491869C4-AF6E-4A3B-9E16-26EBBEAE63FE wds:Q80493152-70DA3E20-3BC1-47C4-8E21-C64D3C156575 wds:Q80493152-9C5F7BDC-FE40-4EDA-B52E-B7E481B53C2F wds:Q80493152-B4E96B14-C567-458D-875C-893E4258A46D wds:Q80493152-C2084785-C589-4CF5-B00F-66F6C8A7AC93 wds:Q80493152-DA928598-3910-485A-B0FC-24C3C2B9ABF2 wds:Q80493152-F0DDDCA0-FD8F-4369-AA3B-0E74245283A5 wds:Q80493152-F9FA9056-029C-4898-97B5-B73C51721396 wds:Q80493152-FC292508-88AE-4525-84DE-5306C368AC0F
author name string	Michael Keating Hagop M Kantarjian Jorge Cortes Thomas J Kipps Susan O'Brien Francis J Giles Kim-Anh Do Deborah Thomas Laura Z Rassenti Marcella M Johnson Iman Jilani
rdfs:label	Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti-CD52 antibodies (en) Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti-CD52 antibodies (nl)
skos:prefLabel	Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti-CD52 antibodies (en) Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti-CD52 antibodies (nl)
name	Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti-CD52 antibodies (en) Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti-CD52 antibodies (nl)
author	wds:Q80493152-FF812B7A-3DDA-4B7D-B9A0-266C07765EBC
author	Maher Albitar
title	wds:Q80493152-C3F55A97-B7CC-4F10-8484-C88A95839408
title	Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti-CD52 antibodies (en)
page(s)	wds:Q80493152-BA274943-BD0D-46F0-9275-AE89740E567D
page(s)	999-1008
instance of	wds:Q80493152-954DECA9-D0B3-4C9D-8F29-A4234B94805F
instance of	scholarly article
main subject	wds:Q80493152-6EB9BBD5-01E9-4D37-A31B-3217E75253B5
main subject	chronic lymphocytic leukemia
PubMed ID	wds:Q80493152-A5EC7978-DD7B-4DFD-9769-FFF1A1801E18
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15329909
PubMed ID	15329909
published in	wds:Q80493152-A8963779-8752-44EE-86F7-54B849E90EDA
published in	Cancer
issue	wds:Q80493152-F99D4210-1A4B-46EC-BB29-412026B388DA
volume	wds:Q80493152-0027AB84-A66F-431D-B8DE-A6E326229973
issue	5
volume	101
DOI	wds:Q80493152-67E2D8C4-E363-4FFD-AA60-E13DC9927C23
DOI	http://dx.doi.org/10.1002/CNCR.20477
DOI	10.1002/CNCR.20477
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q80493152
is cites work of	Increased levels of soluble CD226 in sera accompanied by decreased membrane CD226 expression on peripheral blood mononuclear cells from cancer patients Alemtuzumab by continuous intravenous infusion followed by subcutaneous injection plus rituximab in the treatment of patients with chronic lymphocytic leukemia recurrence Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective study Proteomic-based prediction of clinical behavior in adult acute lymphoblastic leukemia Potential Sources of Inter-Subject Variability in Monoclonal Antibody Pharmacokinetics Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression Circulating Ki-67 index in plasma as a biomarker and prognostic indicator in chronic lymphocytic leukemia Circulating levels and clinical significance of soluble CD40 in patients with hematologic malignancies Heterogeneity in detecting Abl kinase mutations and better sensitivity using circulating plasma RNA Alemtuzumab in allogeneic hematopoetic stem cell transplantation Dynamics of microvesicle generation in B-cell chronic lymphocytic leukemia: implication in disease progression. CD52 as both a marker and an effector molecule of T cells with regulatory action: Identification of novel regulatory T cells Soluble CD22 as a tumor marker for hairy cell leukemia Review of the Clinical Pharmacokinetics and Pharmacodynamics of Alemtuzumab and Its Use in Kidney Transplantation. Rapid diagnosis of chronic myeloid leukemia by flow cytometric detection of BCR-ABL1 protein Enhanced levels of both the membrane-bound and soluble forms of IgM Fc receptor (FcμR) in patients with chronic lymphocytic leukemia SheddomeDB: the ectodomain shedding database for membrane-bound shed markers Pharmacokinetics of Monoclonal Antibodies. Variations in the detection of ZAP-70 in chronic lymphocytic leukemia: Comparison with IgV(H) mutation analysis Establishment a CHO Cell Line Expressing Human CD52 Molecule Circulating CD52 and CD20 levels at end of treatment predict for progression and survival in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab (FCR). Modeling, simulation, and translation framework for the preclinical development of monoclonal antibodies Role of Antisperm Antibodies in Infertility, Pregnancy, and Potential forContraceptive and Antifertility Vaccine Designs: Research Progress and Pioneering Vision The Expression of Microvesicles in Leukemia: Prognostic Approaches Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia. Circulating Ki-67 protein in plasma as a biomarker and prognostic indicator of acute lymphoblastic leukemia
is cites work of	wds:Q43596063-AE4674AC-C316-4748-AD79-75642967917D wds:Q42783346-4B003F56-4C9B-4753-9603-D3E64BC59C79 wds:Q58414413-ACE82025-59EC-4DD1-BAE4-DC0190F2FA54 wds:Q38722163-433F5965-5160-4E48-891E-C033BCAB6A74 wds:Q90133635-81358612-10C8-49EE-A027-6C3B0A243CDA wds:Q37460313-D9A23968-C828-4D82-BD60-DB2D868A81F1 wds:Q35766117-7EA4D020-51E9-40C3-8557-27D8CDCB5AFD wds:Q35766129-E01BBDB9-19CF-433D-BDFA-6209E1E16332 wds:Q36910611-A45A7465-6EE8-44E9-91B1-7BADA7FC2BAE wds:Q92066343-371847A3-4294-4E26-9D44-B0062277A2B3 wds:Q36329547-7C4CD1CC-892B-49E3-BE31-E2839AE8EEE8 wds:Q38917132-EBD23031-F227-4FFB-97BB-961F708FEB1D wds:Q42149544-642638DA-BA0F-47F1-80F5-1670D9A68A0D wds:Q42118646-45FCC900-67BD-4136-9032-C19F1545E246 wds:Q35525598-94FDBBA4-73BA-4C17-B4BF-15F96C5CEE7D wds:Q36868716-397E8113-A541-4FD5-A930-89DD5997F33D

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 170 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software